This document discusses pre-operative assessment and management of patients by anesthesiologists. It covers goals of pre-op care like reducing risk and costs. The anesthesiologist is responsible for determining medical status, developing an anesthesia plan, and informing the patient. A thorough pre-op evaluation can reduce anxiety as much as medication. The document outlines components of the pre-op evaluation including medical history, physical exam, lab tests, and prescribing pre-op medications. Specific considerations for common comorbidities like diabetes and cardiovascular disease are also reviewed.
Pre-operative medication management involves deciding whether to continue or hold chronic medications in the perioperative period. Principles include obtaining a complete medication history, continuing medications that could cause morbidity if withdrawn abruptly, and holding non-essential medications that could increase surgical risk. For many cardiovascular medications like beta blockers, calcium channel blockers, and ACE inhibitors/ARBs, the recommendation is to continue them perioperatively with close monitoring, though some may be held the morning of surgery. Diuretics are often held the morning of surgery to avoid hypotension, while digoxin and statins are generally continued. H2 blockers and proton pump inhibitors are recommended to prevent stress-related gastric issues.
The document discusses peri-operative care, outlining the three phases: pre-operative, intra-operative, and post-operative care. It describes pre-operative care as including patient assessment, history, examinations, investigations, and preparation. Key aspects of pre-operative care are evaluating patient risk factors, medical history, and physical status to determine fitness for surgery and identify risks. The document also discusses classifications of surgery cleanliness and urgency, as well as common post-operative complications.
The document discusses various aspects of pre-operative, operative, and post-operative surgical care including evaluating patient medical history and risk factors, optimizing medical conditions, obtaining informed consent, monitoring vital signs and drainage after surgery, and emphasizing the importance of proper preparation, timing, and follow-up to minimize risks and optimize surgical outcomes. Key factors discussed include cardiac, pulmonary, renal, hepatic, diabetic, nutritional status as well as use of prophylactic antibiotics and measures to prevent thromboembolic events.
The document discusses preoperative care and provides guidelines on evaluating various body systems. It emphasizes performing a thorough history and physical examination to identify any medical conditions or risks. It also recommends specific tests and optimizations for different organ systems like cardiovascular, respiratory, gastrointestinal and others. The goal is to optimize the patient's health and minimize risks so they can undergo surgery safely.
The document discusses the importance of developing thorough anesthesia care plans in 3 stages: prior to the day of surgery, on the day of surgery, and intraoperatively. It emphasizes preparing for potential complications by always having a backup "Plan B." Students are taught to write out care plans to thoroughly assess each case and anticipate any issues. The care planning process involves reviewing the patient's medical history, lab results, and conducting a physical exam. The plan is then discussed with supervisors and patients to obtain consent. Flexibility and being prepared to revise the plan if needed are stressed.
1. Preoperative evaluation by anesthesiologists has changed from being done on the day of surgery to well in advance, due to fewer patients being admitted before surgery and increased medical comorbidities among surgical patients.
2. Anesthesiologists now play a leading role in preoperative clinics to thoroughly evaluate high-risk patients, ensure medical optimization, and plan perioperative care in order to reduce risks and complications.
3. A comprehensive preoperative history and physical examination is important for determining patient-specific risks, developing an anesthetic plan, and obtaining informed consent.
The document discusses guidelines for pre-anesthetic evaluation. It outlines the objectives of pre-anesthetic evaluation as assessing the patient's medical condition, optimizing risks for anesthesia, and obtaining informed consent. Key components of evaluation include medical history, physical exam assessing airway and cardiovascular/respiratory systems, lab tests, and ASA physical status classification. Guidelines are provided for pre-op fasting, medication management, documentation, and conducting evaluations via interview or questionnaires.
Pre-operative medication management involves deciding whether to continue or hold chronic medications in the perioperative period. Principles include obtaining a complete medication history, continuing medications that could cause morbidity if withdrawn abruptly, and holding non-essential medications that could increase surgical risk. For many cardiovascular medications like beta blockers, calcium channel blockers, and ACE inhibitors/ARBs, the recommendation is to continue them perioperatively with close monitoring, though some may be held the morning of surgery. Diuretics are often held the morning of surgery to avoid hypotension, while digoxin and statins are generally continued. H2 blockers and proton pump inhibitors are recommended to prevent stress-related gastric issues.
The document discusses peri-operative care, outlining the three phases: pre-operative, intra-operative, and post-operative care. It describes pre-operative care as including patient assessment, history, examinations, investigations, and preparation. Key aspects of pre-operative care are evaluating patient risk factors, medical history, and physical status to determine fitness for surgery and identify risks. The document also discusses classifications of surgery cleanliness and urgency, as well as common post-operative complications.
The document discusses various aspects of pre-operative, operative, and post-operative surgical care including evaluating patient medical history and risk factors, optimizing medical conditions, obtaining informed consent, monitoring vital signs and drainage after surgery, and emphasizing the importance of proper preparation, timing, and follow-up to minimize risks and optimize surgical outcomes. Key factors discussed include cardiac, pulmonary, renal, hepatic, diabetic, nutritional status as well as use of prophylactic antibiotics and measures to prevent thromboembolic events.
The document discusses preoperative care and provides guidelines on evaluating various body systems. It emphasizes performing a thorough history and physical examination to identify any medical conditions or risks. It also recommends specific tests and optimizations for different organ systems like cardiovascular, respiratory, gastrointestinal and others. The goal is to optimize the patient's health and minimize risks so they can undergo surgery safely.
The document discusses the importance of developing thorough anesthesia care plans in 3 stages: prior to the day of surgery, on the day of surgery, and intraoperatively. It emphasizes preparing for potential complications by always having a backup "Plan B." Students are taught to write out care plans to thoroughly assess each case and anticipate any issues. The care planning process involves reviewing the patient's medical history, lab results, and conducting a physical exam. The plan is then discussed with supervisors and patients to obtain consent. Flexibility and being prepared to revise the plan if needed are stressed.
1. Preoperative evaluation by anesthesiologists has changed from being done on the day of surgery to well in advance, due to fewer patients being admitted before surgery and increased medical comorbidities among surgical patients.
2. Anesthesiologists now play a leading role in preoperative clinics to thoroughly evaluate high-risk patients, ensure medical optimization, and plan perioperative care in order to reduce risks and complications.
3. A comprehensive preoperative history and physical examination is important for determining patient-specific risks, developing an anesthetic plan, and obtaining informed consent.
The document discusses guidelines for pre-anesthetic evaluation. It outlines the objectives of pre-anesthetic evaluation as assessing the patient's medical condition, optimizing risks for anesthesia, and obtaining informed consent. Key components of evaluation include medical history, physical exam assessing airway and cardiovascular/respiratory systems, lab tests, and ASA physical status classification. Guidelines are provided for pre-op fasting, medication management, documentation, and conducting evaluations via interview or questionnaires.
The presentation deals with the basics of pre anesthetic checkups, its only for the educations purpose!
Any kind of replication, modifications and republication is strictly prohibited.
All Rights reserved to the Author. 2016
This document provides guidelines for pre-operative evaluation and risk assessment. It discusses evaluating patients' medication use, medical conditions, functional status, and surgery-specific risk. Key factors that increase cardiac risk include recent heart attack, heart failure, diabetes, and poor functional status. Testing may be warranted for intermediate-high risk surgery or patients with a predicted >1% risk of major cardiac events. Continuation of most medications is reasonable. Statins, aspirin, and beta-blockers in selected patients can reduce risk. Timing of elective surgery depends on prior stenting or heart attack. The goal is to identify and optimize modifiable risks to reduce complications.
preoperative evaluation for residents of anesthesia part 1mansoor masjedi
The document discusses the importance of preoperative evaluation in anesthesia. It notes that anesthesiologists now perform many roles beyond just anesthesia in the operating room, including focused clinical exams, medical optimization, reducing patient anxiety, and informed consent. A thorough preoperative evaluation can reduce surgical risks, delays and cancellations. Key aspects of the evaluation include assessing medical history and physical exam findings, laboratory tests, EKG, and risk classification using the ASA system. The goals are to identify health risks, heart conditions, optimize medical issues, and modify perioperative risk.
The document discusses the importance of pre-anaesthetic checkup and premedication. It outlines the goals of preoperative medical assessment which include reducing surgery morbidity, increasing perioperative care quality while decreasing costs, and helping the patient return to function quickly. The summary also describes the process of taking patient history, examining cardiovascular, respiratory and other systems, assessing airway, and conducting relevant medical tests. Finally, it provides guidelines on premedication for different patient groups and surgeries.
The preoperative evaluation consists of gathering patient information and formulating an anesthetic plan to reduce perioperative risks. Inadequate planning and errors in preparation are common causes of anesthetic complications. The evaluation includes reviewing medical history and test results, performing a physical exam, consulting specialists, and optimizing the patient's medical condition prior to elective surgery. The goal is to ensure the patient is in the best possible state before undergoing anesthesia and procedures.
Role of anesthesiologist in pre-opertive period Khalid
The document discusses the role of anesthesiologists in the pre-operative period. It covers the objectives of the pre-operative visit which include obtaining medical history, identifying risk factors, and determining necessary lab tests. The stages of the peri-operative period - pre-operative, intra-operative, and post-operative - are defined. Key aspects of the pre-operative evaluation that are described include assessing patient risk factors, surgical risk stratification, airway evaluation, and guidelines for pre-operative testing based on procedure, disease conditions, and ongoing therapies.
The document outlines the objectives and components of an anesthesia and CPR course for medical students. It covers pre-anesthesia assessment, orientation to anesthesia equipment, post-operative care, ICU rounds, and the role of anesthesiologists in the pre-operative period. Key topics include pre-anesthesia evaluation, anesthesia principles, medical history taking, risk stratification, airway evaluation, preoperative testing, informed consent, and documenting the preoperative visit.
Given that the patient had a coronary stent placed only 4 weeks ago, continuing both clopidogrel and aspirin would be associated with significant risk of bleeding if he were to undergo emergent neurosurgery. The optimal management would be:
1. Consult cardiology to discuss discontinuing clopidogrel 5-7 days prior to surgery while continuing aspirin. This balances the risks of bleeding vs stent thrombosis.
2. Consider bridging with a short-acting P2Y12 inhibitor like cangrelor on the day of surgery only to further reduce stent thrombosis risk.
3. Monitor the patient closely in the perioperative period for signs of bleeding or stent thrombosis.
Discontinuing both antiplatelets
Pre anaesthetic assessment and preoperative fasting guidelinesAnor Abidin
The document outlines the key steps and objectives of pre-anaesthetic consultation:
- Evaluate the patient's medical condition and optimise any risk factors.
- Determine the anaesthetic technique and perioperative care plan.
- Obtain informed consent from the patient after discussing anaesthesia and the procedure.
- The assessment may involve medical history, physical exam, and targeted lab/imaging tests to evaluate risk.
- The goals are to ensure patient safety and provide preoperative counselling and risk assessment.
This document discusses the importance of preanesthetic evaluation by an anesthesiologist. It aims to ensure patients can safely tolerate anesthesia and mitigate perioperative risks. Key components include documenting medical history, performing examinations, optimizing conditions, ordering tests selectively, and discussing care. History taking and physical exams detect most issues. Tests are only needed based on history, procedure, and anticipated blood loss. The evaluation helps determine a patient's fitness and perioperative risk level. Medication management and fasting guidelines are also reviewed.
This document provides an overview of preanesthesia evaluation. The key purposes are to obtain relevant medical history, assess perioperative risks, order appropriate tests, and formulate an anesthetic plan. Important components of the medical history include past and current medical problems, medications, allergies, and lifestyle factors. A physical exam focuses on vital signs, airway assessment, and systemic examination. For patients with cardiovascular or pulmonary diseases, specific evaluations and tests are recommended to optimize management and identify high-risk patients. The preanesthesia evaluation aims to detect underlying conditions, evaluate perioperative risks, and develop a customized anesthetic plan tailored to each patient's needs.
The document discusses preoperative and postoperative care. It covers preoperative assessment including history taking, physical examination, and risk assessment. Preoperative preparation includes fasting, blood tests, medication administration, and informed consent. Premedication goals are to reduce anxiety, secretions, and nausea/vomiting. Common premeditations include anticholinergics like atropine and scopolamine, benzodiazepines like diazepam and midazolam, and narcotics like pethidine and morphine. Care is taken to minimize risk and ensure patient safety before, during, and after surgery.
This document outlines principles of preoperative care. It discusses evaluating patients' medical history and comorbidities, explaining the planned procedure to obtain informed consent, optimizing high-risk medical conditions before surgery, assessing surgical risk, and preparing patients with bowel cleansing or stopping certain medications. The goal is to minimize risks and optimize outcomes through thorough preoperative evaluation, planning, and preparation.
This document provides guidance on preoperative evaluation and preparation of patients undergoing anesthesia and surgery. It discusses performing a thorough history and physical exam to assess any medical conditions or risks that could impact anesthesia. The goals are to reduce patient risk, modify care as needed, and improve surgical outcomes. Key organ systems to evaluate include respiratory, cardiovascular, neurological, and endocrine. Relevant lab tests may be ordered depending on physical findings. The document also provides guidelines on preoperative preparation for conditions like diabetes and use of steroids to optimize patient health and safety during the perioperative period.
This document discusses perioperative care and preoperative evaluation. It is divided into three phases: preoperative, intraoperative, and postoperative. The preoperative phase begins when the decision for surgery is made and ends when the patient is transferred to the operating room table. This phase involves diagnosis, evaluation of surgical risk factors, preoperative testing, and management of medications. The goal of preoperative evaluation is to optimize the patient's medical condition and minimize risks associated with surgery.
This document discusses guidelines for pre-anesthesia evaluation (PAE). It outlines the components of a PAE, including history taking, physical examination, and relevant investigations. It emphasizes assessing risk factors for perioperative complications, especially related to cardiovascular and pulmonary systems. Modifications to PAE processes during the COVID-19 pandemic are also reviewed, such as taking precautions like masks and distancing.
This document discusses the general care of surgical patients, including the preoperative, intraoperative, and postoperative phases. In the preoperative phase, the patient's medical history is assessed and lab tests are conducted to evaluate their health status and rule out any issues. Tests include blood glucose, electrolytes, kidney and liver function. The intraoperative phase refers to the surgery, while the postoperative phase is the recovery period. Proper care during all phases can help minimize risks and maximize benefits for the patient.
The document discusses performing a pre-operative assessment of surgical patients to identify medical risks and stratify cardiac risk, outlines factors that increase perioperative cardiovascular risk including patient comorbidities, surgery type and functional status, and recommends tests and treatments to optimize patient safety for anesthesia and surgery.
The document discusses the importance of preoperative evaluation in ensuring patient safety and optimal outcomes. A thorough evaluation includes obtaining medical history, conducting a physical exam, and ordering appropriate tests. Key areas of focus include assessing cardiovascular, pulmonary, coagulation, and gastrointestinal status. Airway evaluation helps predict potential difficulties. The goals are to identify and address any issues that could impact anesthesia or surgery, provide informed consent, and reduce risk through optimization when possible.
Dr. S. Siva Sankar presents on perioperative care and outlines key considerations for preoperative planning and patient optimization. This includes gathering relevant patient information, optimizing the patient's medical condition, choosing low-risk surgery, anticipating complications, and ensuring adequate hydration, nutrition and exercise. A thorough history and medical examination is performed focusing on systems relevant to surgery. Routine blood tests and surgery-specific investigations are also done. Specific preoperative conditions like cardiovascular, respiratory, gastrointestinal and endocrine diseases are discussed in terms of optimization and management to reduce surgical risk.
medical evaluation of the surgical patientAmit Shrestha
The document provides guidelines for preoperative medical evaluation and optimization of surgical patients. It discusses grading surgical risk, collecting patient history and health information, assessing cardiac and pulmonary risk, managing common comorbidities like diabetes, and recommending prophylaxis for infections and blood clots. Key aspects include using standardized questionnaires; evaluating risk factors like age, functional status and clinical markers; providing preventative therapies like beta blockers and statins as needed; and implementing measures to reduce pulmonary and thrombotic complications through the pre-, intra-, and postoperative periods.
This document summarizes key considerations for anesthesia management in elderly patients undergoing emergency surgery. It recommends preoperative optimization, careful titration of anesthetic drugs due to increased sensitivity in elderly, and goal-directed resuscitation for patients presenting with abdominal emergencies. Regional anesthesia is preferred over general anesthesia for hip surgeries when possible. Close postoperative monitoring in the ICU is important for high-risk elderly patients after emergency laparotomy to improve outcomes.
The presentation deals with the basics of pre anesthetic checkups, its only for the educations purpose!
Any kind of replication, modifications and republication is strictly prohibited.
All Rights reserved to the Author. 2016
This document provides guidelines for pre-operative evaluation and risk assessment. It discusses evaluating patients' medication use, medical conditions, functional status, and surgery-specific risk. Key factors that increase cardiac risk include recent heart attack, heart failure, diabetes, and poor functional status. Testing may be warranted for intermediate-high risk surgery or patients with a predicted >1% risk of major cardiac events. Continuation of most medications is reasonable. Statins, aspirin, and beta-blockers in selected patients can reduce risk. Timing of elective surgery depends on prior stenting or heart attack. The goal is to identify and optimize modifiable risks to reduce complications.
preoperative evaluation for residents of anesthesia part 1mansoor masjedi
The document discusses the importance of preoperative evaluation in anesthesia. It notes that anesthesiologists now perform many roles beyond just anesthesia in the operating room, including focused clinical exams, medical optimization, reducing patient anxiety, and informed consent. A thorough preoperative evaluation can reduce surgical risks, delays and cancellations. Key aspects of the evaluation include assessing medical history and physical exam findings, laboratory tests, EKG, and risk classification using the ASA system. The goals are to identify health risks, heart conditions, optimize medical issues, and modify perioperative risk.
The document discusses the importance of pre-anaesthetic checkup and premedication. It outlines the goals of preoperative medical assessment which include reducing surgery morbidity, increasing perioperative care quality while decreasing costs, and helping the patient return to function quickly. The summary also describes the process of taking patient history, examining cardiovascular, respiratory and other systems, assessing airway, and conducting relevant medical tests. Finally, it provides guidelines on premedication for different patient groups and surgeries.
The preoperative evaluation consists of gathering patient information and formulating an anesthetic plan to reduce perioperative risks. Inadequate planning and errors in preparation are common causes of anesthetic complications. The evaluation includes reviewing medical history and test results, performing a physical exam, consulting specialists, and optimizing the patient's medical condition prior to elective surgery. The goal is to ensure the patient is in the best possible state before undergoing anesthesia and procedures.
Role of anesthesiologist in pre-opertive period Khalid
The document discusses the role of anesthesiologists in the pre-operative period. It covers the objectives of the pre-operative visit which include obtaining medical history, identifying risk factors, and determining necessary lab tests. The stages of the peri-operative period - pre-operative, intra-operative, and post-operative - are defined. Key aspects of the pre-operative evaluation that are described include assessing patient risk factors, surgical risk stratification, airway evaluation, and guidelines for pre-operative testing based on procedure, disease conditions, and ongoing therapies.
The document outlines the objectives and components of an anesthesia and CPR course for medical students. It covers pre-anesthesia assessment, orientation to anesthesia equipment, post-operative care, ICU rounds, and the role of anesthesiologists in the pre-operative period. Key topics include pre-anesthesia evaluation, anesthesia principles, medical history taking, risk stratification, airway evaluation, preoperative testing, informed consent, and documenting the preoperative visit.
Given that the patient had a coronary stent placed only 4 weeks ago, continuing both clopidogrel and aspirin would be associated with significant risk of bleeding if he were to undergo emergent neurosurgery. The optimal management would be:
1. Consult cardiology to discuss discontinuing clopidogrel 5-7 days prior to surgery while continuing aspirin. This balances the risks of bleeding vs stent thrombosis.
2. Consider bridging with a short-acting P2Y12 inhibitor like cangrelor on the day of surgery only to further reduce stent thrombosis risk.
3. Monitor the patient closely in the perioperative period for signs of bleeding or stent thrombosis.
Discontinuing both antiplatelets
Pre anaesthetic assessment and preoperative fasting guidelinesAnor Abidin
The document outlines the key steps and objectives of pre-anaesthetic consultation:
- Evaluate the patient's medical condition and optimise any risk factors.
- Determine the anaesthetic technique and perioperative care plan.
- Obtain informed consent from the patient after discussing anaesthesia and the procedure.
- The assessment may involve medical history, physical exam, and targeted lab/imaging tests to evaluate risk.
- The goals are to ensure patient safety and provide preoperative counselling and risk assessment.
This document discusses the importance of preanesthetic evaluation by an anesthesiologist. It aims to ensure patients can safely tolerate anesthesia and mitigate perioperative risks. Key components include documenting medical history, performing examinations, optimizing conditions, ordering tests selectively, and discussing care. History taking and physical exams detect most issues. Tests are only needed based on history, procedure, and anticipated blood loss. The evaluation helps determine a patient's fitness and perioperative risk level. Medication management and fasting guidelines are also reviewed.
This document provides an overview of preanesthesia evaluation. The key purposes are to obtain relevant medical history, assess perioperative risks, order appropriate tests, and formulate an anesthetic plan. Important components of the medical history include past and current medical problems, medications, allergies, and lifestyle factors. A physical exam focuses on vital signs, airway assessment, and systemic examination. For patients with cardiovascular or pulmonary diseases, specific evaluations and tests are recommended to optimize management and identify high-risk patients. The preanesthesia evaluation aims to detect underlying conditions, evaluate perioperative risks, and develop a customized anesthetic plan tailored to each patient's needs.
The document discusses preoperative and postoperative care. It covers preoperative assessment including history taking, physical examination, and risk assessment. Preoperative preparation includes fasting, blood tests, medication administration, and informed consent. Premedication goals are to reduce anxiety, secretions, and nausea/vomiting. Common premeditations include anticholinergics like atropine and scopolamine, benzodiazepines like diazepam and midazolam, and narcotics like pethidine and morphine. Care is taken to minimize risk and ensure patient safety before, during, and after surgery.
This document outlines principles of preoperative care. It discusses evaluating patients' medical history and comorbidities, explaining the planned procedure to obtain informed consent, optimizing high-risk medical conditions before surgery, assessing surgical risk, and preparing patients with bowel cleansing or stopping certain medications. The goal is to minimize risks and optimize outcomes through thorough preoperative evaluation, planning, and preparation.
This document provides guidance on preoperative evaluation and preparation of patients undergoing anesthesia and surgery. It discusses performing a thorough history and physical exam to assess any medical conditions or risks that could impact anesthesia. The goals are to reduce patient risk, modify care as needed, and improve surgical outcomes. Key organ systems to evaluate include respiratory, cardiovascular, neurological, and endocrine. Relevant lab tests may be ordered depending on physical findings. The document also provides guidelines on preoperative preparation for conditions like diabetes and use of steroids to optimize patient health and safety during the perioperative period.
This document discusses perioperative care and preoperative evaluation. It is divided into three phases: preoperative, intraoperative, and postoperative. The preoperative phase begins when the decision for surgery is made and ends when the patient is transferred to the operating room table. This phase involves diagnosis, evaluation of surgical risk factors, preoperative testing, and management of medications. The goal of preoperative evaluation is to optimize the patient's medical condition and minimize risks associated with surgery.
This document discusses guidelines for pre-anesthesia evaluation (PAE). It outlines the components of a PAE, including history taking, physical examination, and relevant investigations. It emphasizes assessing risk factors for perioperative complications, especially related to cardiovascular and pulmonary systems. Modifications to PAE processes during the COVID-19 pandemic are also reviewed, such as taking precautions like masks and distancing.
This document discusses the general care of surgical patients, including the preoperative, intraoperative, and postoperative phases. In the preoperative phase, the patient's medical history is assessed and lab tests are conducted to evaluate their health status and rule out any issues. Tests include blood glucose, electrolytes, kidney and liver function. The intraoperative phase refers to the surgery, while the postoperative phase is the recovery period. Proper care during all phases can help minimize risks and maximize benefits for the patient.
The document discusses performing a pre-operative assessment of surgical patients to identify medical risks and stratify cardiac risk, outlines factors that increase perioperative cardiovascular risk including patient comorbidities, surgery type and functional status, and recommends tests and treatments to optimize patient safety for anesthesia and surgery.
The document discusses the importance of preoperative evaluation in ensuring patient safety and optimal outcomes. A thorough evaluation includes obtaining medical history, conducting a physical exam, and ordering appropriate tests. Key areas of focus include assessing cardiovascular, pulmonary, coagulation, and gastrointestinal status. Airway evaluation helps predict potential difficulties. The goals are to identify and address any issues that could impact anesthesia or surgery, provide informed consent, and reduce risk through optimization when possible.
Dr. S. Siva Sankar presents on perioperative care and outlines key considerations for preoperative planning and patient optimization. This includes gathering relevant patient information, optimizing the patient's medical condition, choosing low-risk surgery, anticipating complications, and ensuring adequate hydration, nutrition and exercise. A thorough history and medical examination is performed focusing on systems relevant to surgery. Routine blood tests and surgery-specific investigations are also done. Specific preoperative conditions like cardiovascular, respiratory, gastrointestinal and endocrine diseases are discussed in terms of optimization and management to reduce surgical risk.
medical evaluation of the surgical patientAmit Shrestha
The document provides guidelines for preoperative medical evaluation and optimization of surgical patients. It discusses grading surgical risk, collecting patient history and health information, assessing cardiac and pulmonary risk, managing common comorbidities like diabetes, and recommending prophylaxis for infections and blood clots. Key aspects include using standardized questionnaires; evaluating risk factors like age, functional status and clinical markers; providing preventative therapies like beta blockers and statins as needed; and implementing measures to reduce pulmonary and thrombotic complications through the pre-, intra-, and postoperative periods.
This document summarizes key considerations for anesthesia management in elderly patients undergoing emergency surgery. It recommends preoperative optimization, careful titration of anesthetic drugs due to increased sensitivity in elderly, and goal-directed resuscitation for patients presenting with abdominal emergencies. Regional anesthesia is preferred over general anesthesia for hip surgeries when possible. Close postoperative monitoring in the ICU is important for high-risk elderly patients after emergency laparotomy to improve outcomes.
The document provides guidance on preoperative anesthesia evaluations. It discusses why evaluations are important for patients, anesthesiologists, and surgeons. The evaluation should obtain a thorough medical history, physical exam including airway assessment, review medications and labs/tests needed based on surgery risk. Comorbidities like diabetes and hypertension are addressed. The goal is to optimize patient health and develop an anesthetic plan to reduce risks during surgery.
This document discusses preoperative evaluation and risk assessment for non-cardiac surgery. It outlines how to evaluate patients' surgical risk based on their medical history, functional status, and type of surgery. Factors like age, diabetes, kidney function, and cardiovascular health can increase surgical risk. The document provides guidelines on optimizing high-risk patients medically before elective surgery through measures like controlling blood sugar, hypertension, and anemia. It also reviews strategies to reduce risks like pulmonary complications through breathing exercises.
Thank you for the detailed presentation on medical emergencies in the dental office. I appreciate you taking the time to educate us on this important topic to help ensure patient safety.
Perioperative managment of neurological patientsnagy shenoda
This document provides guidance on the perioperative management of patients with various neurological diseases. It outlines considerations for patients with cerebrovascular stroke, epilepsy, neuromuscular disorders, muscle diseases, peripheral neuropathies, Parkinson's disease, multiple sclerosis, and Alzheimer's disease. Key recommendations include continuing antiplatelet therapies for stroke patients during many procedures, maintaining epilepsy patients' regular anticonvulsant medications, assessing respiratory function for neuromuscular disease patients, and timing Parkinson's disease medications around surgery to avoid complications. Careful planning is needed to minimize risks for each condition.
The document discusses the process and objectives of pre-anesthesia checkups (PACs). A PAC involves assessing a patient's medical history, conducting a physical exam, and developing an anesthesia plan. It aims to evaluate perioperative risk and ensure a patient can safely tolerate anesthesia. Key parts of the evaluation include reviewing the cardiovascular, respiratory, and other organ systems, as well as performing airway exams and risk assessments. The PAC provides important information to inform anesthesia management and optimize patient safety and outcomes.
The document discusses stroke management and treatment. It states that ideally patients are admitted to a dedicated stroke unit staffed by nurses and therapists experienced in stroke care, where patients have a higher chance of survival than elsewhere in the hospital. Stroke treatment is highly variable depending on factors like the location and severity of the blockage or bleeding in the brain. Treatment aims to prevent further damage, reduce risk factors, and help the patient regain independence through rehabilitation.
Anaesthetic considerations in diabetes mellitus (1)hassam2
The document discusses anaesthetic considerations for patients with diabetes mellitus. It notes that the preanesthesia evaluation should include assessing the patient's type of diabetes, level of blood glucose control, and medication regimen. It also discusses implications for different types of diabetes, implications of regional anesthesia, diabetic complications like nephropathy and implications for airway management. The document provides guidance on adjustments to insulin regimens prior to surgery depending on the patient's usual insulin doses and risk of hypoglycemia.
This document summarizes the results of a randomized, prospective, open-label clinical trial evaluating the efficacy and safety of Sulfad tablets for the management of non-alcoholic steatohepatitis (NASH) patients. The trial involved 100 patients taking Sulfad tablets for 3 months. Significant improvements were seen in liver enzymes and lipid profiles after 1, 2, and 3 months of treatment. No major safety issues were reported. The study concluded that Sulfad tablets were well-tolerated and effective for the management of NASH patients.
efficacy and safety of Sulfad tablets in the management of NASH
patients: A randomized ,prospective, open label, multi-center,
controlled, phase III clinical trial.
This document reviews recommendations for managing chronic medication therapies in the perioperative period based on a literature review. It summarizes guidelines for various drug classes, including cardiovascular drugs like beta-blockers which should generally be continued, and ACE inhibitors/ARBs which may need to be discontinued. It also reviews antiplatelet drugs like aspirin that may need to be stopped before some surgeries depending on bleeding risk. Recommendations are provided for anticoagulants as well, noting that factors like kidney function and surgery bleeding risk must be considered for drugs like the new oral anticoagulants. The review aims to help clinicians safely manage patients' chronic medications in the perioperative setting.
Elderly patient - Comorbidities and Anesthetic Challenges - Medicine - ATOTDr. Salman Ansari
Topic: Elderly Patient
Faculty: Medicine
Course: BSc ATOT - 2nd year
Subtopics:
- Physiological changes seen in elderly
- Comorbidities in elderly
- Anesthetic challenges in elderly
- Preoperative evaluation
- Intraoperative care
- Postoperative care
- Postoperative Cognitive Dysfunction(POCD)
This document provides guidance on patient assessment prior to surgery. It outlines the importance of correcting medical issues like anemia and diabetes, as well as gaining an understanding of a patient's history and comorbidities to estimate surgical risks. The assessment involves taking a thorough history, conducting an examination, and ordering relevant investigations. High-risk patients are identified and their management is optimized to reduce postoperative morbidity and mortality. The document provides detailed guidance on assessing various organ systems and comorbidities, and developing perioperative management plans tailored to individual patient needs and risks.
The patient, a 50-year-old female, presented with headache, vomiting, breathlessness and decreased urine output. She had a history of rheumatic heart disease for 4 years and was on warfarin therapy. Investigation revealed subdural hematoma which resolved after stopping warfarin. The final diagnosis was rheumatic heart disease with severe mitral stenosis, pulmonary hypertension, congestive cardiac failure, atrial fibrillation and warfarin-induced acute subdural hematoma.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
4. anesthesiologist shall be responsible for
determining the medical status of the patient
developing a plan of anesthesia care
acquainting the patient with the proposed plan
ASA
7/15/2014 4
5. study evaluating methods of reducing preoperative
anxiety
thorough preoperative evaluation can be as effective as
an anxiolytic premedication
7/15/2014 5
6. Review available medical records
Interview and perform focused examination of the patient
Discuss medical hx, including previous anesthetic experiences and
medical therapy
Assess those aspects of the patient’s physical condition that might
affect decisions regarding perioperative risk and management.
Order/ review pertinent available tests and consultations as
necessary for the delivery of anesthesia care
Order appropriate preoperative medications
Ensure that consent has been obtained for the anesthesia
care- BRAN (benefit, risks, alternatives, if Not done then..)
Document in the chart that the above has been performed
7/15/2014 6
7. Current Problem- History of present illness
The proposed surgery – affects type of anaesthesia/ position
Other known problems- Any comorbidities (DM, HTN,
psychiatric illness)
Drug history- Present therapy (prescription/ over-the-
counter), alcohol, tobacco
Allergy history- drugs, food, latex, etc.
Anesthetic history- Previous anesthetics, operations,
complications, h/o malignant hyperthermia (“allergy to
anesthesia”)
System review- Screening of any undiagnosed systemic
illnesses
Miscellaneous- Last oral intake (ER) 7/15/2014 7
8. General appearance- Comfortable, in distress, sick
looking, physique, wt, ht, BMI
Vital signs- Temp, pulse, BP, RR
Head to toe examination- Pallor, icterus, clubbing,
cyanosis, edema, dehydration, peripheral veins,
pre-existing iv cannulae
7/15/2014 8
9. dentition- loose or chipped teeth, caps, bridges, or
dentures
poor anesthesia mask fit expected in edentulous patients and
significant facial abnormalities
prominent upper incisors, large tongue, short neck suggest
difficulty may be encountered during tracheal intubation
nostrils
thyromental distance: 5cms
Sternomental distance: 12.5 cms
mandibular protrusion test
flexon and Extension of the neck
Cervical spine- Important in trauma, RA, cervical
spondylosis 7/15/2014 9
11. A screening evaluation regarding history of tobacco use,
shortness of breath, cough, wheezing, stridor, snoring or
sleep apnea
recent history of an upper respiratory tract infection
Patient's ability to carry on a conversation or to walk
without dyspnea
Physical exam- assess the respiratory rate as well as the
chest excursion, use of accessory muscles
Auscultation to detect decreased breath sounds, wheezing,
stridor
7/15/2014 11
12. Site of surgery
thoracic, aortic or upper abdominal surgery has highest risk
Type of surgery
abdominal aortic aneurysm repair, thoracic, upper abdominal have
highest risks followed by neck, peripheral vascular, and
neurosurgery
Neurosurgery and neck surgery associated with perioperative
aspiration pneumonia
Laparoscopic surgery have lesser risk than open surgery
Duration of surgery
longer the duration, longer the time exposure to anesthesia
7/15/2014 12
13. tobacco/ smoking
increase carboxy-hemoglobin
decrease ciliary function
increase sputum production
stimulates cardiovascular system secondary to nicotine
asthma/COPD
increased airway responsiveness
drugs may have adverse reactions with anesthetics
chronic CO2 retention in COPD
obstructive sleep apnea
susceptible to the respiratory depressant and airway effects of
sedatives, narcotics, and inhaled anesthetics
7/15/2014 13
14. General appearance including weight, BMI
Vital signs
Pulse and its characteristics( rate, rhythm, character, volume, delay,
all peripheral pulses)
BP (if needed in both arms)
Temperature, RR
Head to toe examination
JVP, anemia, cyanosis, clubbing, edema
Precordial examination
Inspection/Palpation- apical impulse, heave, thrills
Auscultation- heart sounds, murmurs
Auscultation of basal lung fields
Assessment of liver size and position
7/15/2014 14
15. Age
associated with multisystem disease,
Previous MI
5-8% risk of periop reinfarction
Mortality rate of reinfarction 36-70%
Risk of reinfarction decreases with time
30% <3 mnths
6% >6mnths
CHF
symptomatic CHF- predictor of perioperative pulmonary
edema
Hypertension
Leading cause of concern
Not a significant risk factor alone (esp. if <180/110), but due
its end-organ damage like LVF, renal failure and stroke
7/15/2014 15
16. DM
risk of CAD, silent MI, renal insufficiency
Equal risk as nondiabetics with previous MI
VHD
AS- 14 fold greater risk as compared with those without AS
risk of IE
Arrhythmias
Frequent PVCs and nonsinus rhythms
CHB, LBBB, 2 heart block (Mobitz type II)
Others
Smoking, hyperlipidemia, renal failure, anemia, depression,
hypoalbuminemia
Inflammatory markers: CRP, b-type natriuretic peptide
7/15/2014 16
17. Renal disease- important implications for fluid
management and metabolism of drugs.
Liver disease -associated with altered protein binding,
volume of distribution of drugs, coagulation abnormalities
Musculoskeletal System- anatomy evaluated for procedures
such as a nerve block, regional anesthesia, invasive
monitoring
Neurological- history of prior stroke -increased risk for a
perioperative stroke
7/15/2014 17
19. CBC
Ur. / Cr.
Na/ K
PT/ INR
CXR
ECG
Urine RE/ME
Other case pertinent inv.
7/15/2014 19
20. MET, metabolic
equivalent of the
task. 1 MET =
consumption of
3.5 mL O2/min/kg of
body weight.
Patients with MET less
than 4 or 5 have
higher risk of
perioperative cardiac
morbidity
7/15/2014 20
21. NYHA: New york Heart Association
CCVSA: Canadian Cardiovascular Society
7/15/2014 21
23. administration of drugs prior to anesthesia
to allay apprehension
produce sedation
facilitate the administration of anesthesia to the patient
7/15/2014 23
24. Devoid of any side effects
Minimal depression of respiration and
cardiovascular function.
Simple and pleasant to take.
Should act over reasonable period of time.
Should be effective in all patients.
7/15/2014 24
25. Relief of anxiety
Sedation
Amnesia
Analgesia
Drying of airway secretions
Prevention of autonomic
reflex responses
Reduction of gastric fluid
volume and increased pH
Antiemetic effects
Reduction of anesthetic
requirements
Facilitation of smooth
induction of anesthesia
Prophylaxis against
allergic reactions
7/15/2014 25
26. anxiolytics
Children- syr promethazine (6.25 mg/ml)
5- 10 ml hs/ cm
Young adults- diazepam
5-10 mg hs/ cm
Elderly –lorazepam
1- 2mg hs/ cm
Antiemetics
Antacids/ ppi
7/15/2014 26
27. Hypertension
Antihypertensive drugs to be continued except Losartan &
Diuretics
• RHD
• Prophylactic antibiotics should be considered
• Patients on anticoagulant therapy- warfarin should be substituted
by heparin 3-5 days prior to surgery
• IHD-
• Anticholinergic mainly atropine to be avoided.
• Aspirin to be discontinued 7 days before surgery
7/15/2014 27
28. • Bronchodilators, steroids should be continued
• Prophylactic antibiotics in COPD patients
• Inhaled β2-agonists, cromolyn, or steroids should be
continued up to the time of surgery
7/15/2014 28
29. Objectives
• avoid hypoglycemia, excessive hyperglycemia,
ketoacidosis
• metformin should be held if there is decreased renal
function- risk for the fear of Lactic acidosis.
• glimepiride (Sulfonylureas) should be held while the pt.
is NPO
• Thiazolidinedione can be continued as they do not
predispose to hypoglycemia
• α-glucosidase inhibitor should be held
• Premedication to avoid aspiration, N/V
7/15/2014 29
30. Well-controlled type 2 diabetics do not require insulin for
minor surgery.
Poorly controlled type 2 diabetics and all type 1 diabetics
having minor surgery and all diabetics having major
surgery need insulin.
For major surgery, serum glucose > 270 mg/dL, the surgery
should be delayed while rapid control is achieved with
intravenous insulin.
If the serum glucose >400 mg/dL, surgery should be
postponed and the metabolic state restabilized.
7/15/2014 30
31. Administer 1/2 to 2/3rd of the patient's usual intermediate-
acting insulin subcutaneously on the morning of surgery
In addition to this basal insulin, a regular insulin sliding
scale (RISS) can be added and titrated to blood glucose
measurement.
Alternatively, an insulin infusion of 1 to 2 U/hr (100 U
regular insulin in 100 mL normal saline at 1 to 2 mL/hr) can
meet basal metabolic needs and be adjusted to maintain
blood glucose at the desired level.
7/15/2014 31
32. With either method, a slow glucose infusion (dextrose 5%
in water at 75 to 100 mL/hr) will prevent hypoglycemia
while the patient is fasting.
Some authorities recommend a combination glucose-
insulin or glucose-insulin-potassium infusions (GIK)
7/15/2014 32
34. 7/15/2014 34
Management of Diabetes Mellitus in Surgical Patients
http://spectrum.diabetesjournals.org/content/15/1/44.full
35. Intraoperative GIK solution given to diabetic patients with
CABG operation provides more stable CI, shorter time of
MV, more stable values of potassium which provides
normal rhythm and less AF onset, less insulin to maintain
target glycemia. All the above mentioned provides more
stable intraoperative hemodynamic and better recovery of
diabetic
Glucose-Insulin-Potassium (GIK) solution used with
diabetic patients provides better recovery after
coronary bypass operations.
Straus S, Gerc V, Kacila M, Faruk C.
7/15/2014 35
36. “Sliding scale insulin” is not recommended for the
management of hyperglycemia.
“set and forget”
Basal + pre-meal better
https://www.diabetessociety.com.au/documents/Periop
erativeDiabetesManagementGuidelinesFINALCleanJuly
2012.pdf
7/15/2014 36
37. Type II patients taking oral agents alone, RISS can be
added to control blood glucose levels.
Patients receiving chronic insulin can be treated similarly
to the type I patient by giving 1/2 the usual NPH insulin
dose the morning of surgery, supplemented by a RISS, or
an insulin infusion titrated to blood glucose.
7/15/2014 37
39. state of drug induced reversible unconsciousness
and loss of protective reflexes
consist of hypnosis, amnesia, analgesia, relaxation of
skeletal muscles, and loss of autonomic reflexes
Balanced anesthesia=
hypnotic+ amnesic + analgesics + muscle
relaxant
7/15/2014 39
40. Components of GA
Pre-anesthetic check up (PAC)
Premedication
Induction
Maintenance
Recovery
Postoperative Care
7/15/2014 40
41. Advantages
fast onset of anesthesia than inhalation, (10-20 seconds)
induce total unconsciousness
avoidance of the excitatory phase of anesthesia (Stage II)
complications related to induction of anesthesia.
7/15/2014 41
42. Propofol (10 mg/ml)-
<55 yr – 2- 2.5mg/ kg slow iv
>55 yr- 1-1.5 mg/kg slow iv
Onset 30- 45 s
Duration- 20-75 min
Metabolism- hepatic conjugation
Excretion- urine
s/e- injection site burning, hypotension, apnea, rash
pruritus, cardiac s/e
Most commonly used
7/15/2014 42
43. Ketamine (10mg/ml)
1-4.5 mg/kg slow iv once
1-2 mg/ kg infusion @ 0.5mg/kg/min
Produces dissociative anesthesia
Blocks NMDA receptors
Onset- 30 s
Duration- 5 -10 mins
Metabolised by liver
Excreted in urine
s/e- emergence reaction, htn, raised ICP, tachycardia,
hallucinations
7/15/2014 43
44. Sodium thiopental
ultra-short-acting barbiturate
4–6 mg/kg
Largely replaced by propofol
mainly metabolized to pentobarbital
s/e- hypotension, apnea and airway obstruction
caution with liver disease, severe heart disease,
severe hypotension, a severe breathing disorder, or a family
history of porphyria
Etomidate (2mg/ml)
0.3-.6 mg/ kg iv over a minute
Onset 60s; duration- 3-5 mins
Hepatic metabolism, excreted in urine
s/e- adrenal suppression, pain, apnea, arrythmias
Less often used
7/15/2014 44
45. Advantages:
Excellent analgesia
Minimal hemodynamic depression
Good suppression of endotracheal tube response
Problems:
Respiratory depression
Incomplete suppression of intraoperative awareness
Used mainly for cardiac anesthesia and also in smaller
doses as a part of balanced anesthesia for non-cardiac
cases
7/15/2014 45
46. Fentanyl
More lipid soluble than morphine
Rapid onset (60 sec)
Elimination half time (200 min) is longer than the
duration of clinical effect
Very highly bound to lung as a function of time. So half-
life of effect depends upon duration of administration
because of an increase in storage.
Available as IV, transdermal patch & lollipop
7/15/2014 46
47. Isoflurane
1- 3%
Rapid onset, short acting
MAC 1.3%
s/e N/V, hypotension, arrythmias
Sevoflurane
1.4- 2.6%
Onset 2-3 min
expensive
s/e hypotension, respiratory irritation, seizures
Halothane
potent anesthetic
MAC 0.74
20% metabolized in liver
s/e- liver injury 1in 10,000
Less preferred 7/15/2014 47
48. Difficult IV access
Anticipated difficult airway
Children
7/15/2014 48
49. used for
facilitate intubation of the trachea
facilitate mechanical ventilation
optimize surgical working conditions
Depolarizing muscle relaxant
Succinylcholine
Nondepolarizing muscle relaxants
Short acting
Intermediate acting
Long acting
7/15/2014 49
51. Succinylcholine
Most often used to facilitate intubation
dose- 1-1.5 mg/kg
Onset 30-60 seconds
duration 5-10 minutes
s/e- Cardiovascular, Fasciculation Muscle pain,
Increase IOP, Increase ICP, intragastric
pressure
Malignant hyperthermia
7/15/2014 51
52. Nondepolarizing Muscle Relaxants
Do not depolarized the motor endplate
Act as competitive antagonist
Excessive concentration causing channel blockade
Act at presynaptic sites, prevent movement of Ach to
release sites
Long acting
Pancuronium
Intermediate acting
Atracurium, Vecuronium, Rocuronium, Cisatracurium
Short acting
Mivacurium
7/15/2014 52
53. Vecuronium
Analogue of pancuronium
much less vagolytic effect and shorter duration than
pancuronium
Onset 3-5 minutes
duration 20-35 minutes
Intubating dose 0.08-0.12 mg/kg
Elimination 40% by kidney, 60% by liver
7/15/2014 53
54. Neostigmine
0.03-0.07 mg/kg iv
Max dose 5mg
10-20 mins
Competitive inhibitor of choliesterase
Reverses action of muscle relaxants
Administered with anticholinergics
Atropine (
Glycopyrrolate (0.2 mg per 1 mg of neostigmine)
7/15/2014 54
55. Miller’s Anaesthesia- 7th Edition
Clinical Anaesthesia – Paul G. Barash, 6th Edition
ACC/AHA guidelines on perioperative cardiovascular
assessment
Uptodate 21.2
Medscape
www.asahq.org
http://spectrum.diabetesjournals.org/content/15/1/44.
full
7/15/2014 55